Archives

by in
Entry Author Date Location
The Second Xconomy Boston Healthcare Summit: Request An Invitation 10/02/14 Boston
Microbiome Startup Seres Health Tabs Pharma Vet Pomerantz as CEO 06/02/14 Boston
Dean Kamen: Coptering In to Inspire Crowd at Boston 2034 on June 10 06/02/14 Boston
Boston 2034: The Big Agenda for Our June 10 Innovation Conference 05/21/14 Boston
Get a Window on the Innovation Future at Boston 2034 on June 10 05/07/14 Boston
Learn the Future of New England Innovation: Announcing Boston 2034 03/31/14 Boston
Flagship’s Pronutria Emerges to Make Medicines and Medical Foods 10/22/13 Boston
Boston’s Life Science Disruptors: The Photos 10/07/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
Bluebird, Moderna, Genocea to Share Their Stories on Oct. 2 09/12/13 Boston
Which VCs Are Poised to Profit From the Biotech IPO Boom? 09/09/13 National
Join Us, and Boston’s “Life Science Disruptors,” on Oct. 2 08/21/13 Boston
Joule Swaps CEOs, Raises $50M More for Renewable Fuels 08/20/13 Boston
Constructing Innovation Supply Chains for the Pharmaceutical Industry 06/26/13 Boston
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Can Biotech Learn From the TV Production Market? 04/26/13 National
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
Boston Life Sciences 2032: The Photos 10/11/12 Boston
LS9 Scales Up in Chemical Business As Biofuels Industry Re-Tools 10/04/12 San Francisco
MGH Medicine Head Ausiello to Join Oct. 4 Xconomy Life Science Forum 09/24/12 Boston
Merck Teams With Flagship to Bankroll Early Biotech Ventures 04/10/12 Boston
Boston Business Leaders Reflect on Susan Hockfield’s MIT Presidency 02/16/12 Boston
Flagship Closes New $270M Fund For Healthcare and Cleantech Ventures 01/11/12 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
Controversial Companies Are Good, VCs Are Getting Active, and the Entrepreneurial Generation Is Rising: 10 Takeaways from Xconomy’s VC65 04/12/11 Boston
The VC65 Photo Gallery: Happy 65th Birthday, Venture Capital 04/08/11 Boston
Thanks to Our VC65 Speakers, Sponsors, and Partners 04/08/11 Boston
Page 1 of 2 next page »